نتائج البحث - "Irene Langner"

المصدر: BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)

مصطلحات موضوعية: Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, Article Subject, Long acting insulin, Cost-Benefit Analysis, Health authority, medicine.medical_treatment, Pharmaceutical policy, Insulin Glargine, Genetics and Molecular Biology, General Biochemistry, Genetics and Molecular Biology, Patient Education as Topic, Systematic reviews (Medical research), Diabetes Mellitus, medicine, Humans, Hypoglycemic Agents, Poor glycaemic control, Drugs -- Costs, Biosimilar Pharmaceuticals, General Immunology and Microbiology, Public economics, Insulin glargine, Insulin, Stakeholder, Biosimilar, Health Care Service and Management, Health Policy and Services and Health Economy, General Medicine, Europe, Insulin, Long-Acting, Eastern european, Diabetes -- Patients -- Europe, General Biochemistry, Medicine, Business, Research Article, medicine.drug

وصف الملف: application/pdf; text/xhtml

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US

View record at Wiley

Find this article in full text from ProQuest

7

Variation in the prices of oncology medicines across Europe and the implications for the future

المؤلفون: Wouter Hamelinck, Elita Poplavska, Ott Laius, Ruaraidh Hill, Jurij Fürst, Dzintars Gotham, Iva Selke Krulichová, Zornitza Mitkova, Ileana Mardare, Andrew F. Hill, Stuart McTaggart, Brian Godman, Corrine Zara, Vanda Marković-Peković, Patricia Vella Bonanno, Mark Parker, Caridad Pontes, Katarina Banasova, Tanja Novakovic, John Yfantopoulos, Janet Wale, Irene Langner, Hans Piepenbrink, Christian Hierländer, Peter Skiold, Guenka Petrova, Magdalene Wladysiuk, Amanj Kurdi, Vincent de Valk, Stephen Campbell, Anna Nachtnebel, Admir Malaj, Roberta Joppi, Angela Timoney, Maria Juhasz-Haverinen, Antony P. Martin, Jolanta Gulbinovič, Merce Obach Cortadellas, Iris Hoxha, Arianit Jakupi, Durhane Wong-Rieger, Catherine Sermet, D Tomek, Gisbert Selke, Eleonora Allocati, Ieva Greiciute-Kuprijanov, Tomasz Bochenek, Steven Simoens, Robert Plisko

المصدر: University of Strathclyde

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Scrutiny, Population size, Biosimilar, Pharmacy, RS, Drug Guides, Internal medicine, Value (economics), Sustainability, medicine, Per capita, Business, health care economics and organizations, Health policy, Economic power

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77151d4ac5e7399df29d92a7faac2a6
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf

8

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

المؤلفون: Ruaraidh Hill, Christian Hierländer, Carolina Zampirolli Dias, Tomasz Bochenek, Ott Laius, Lars L. Gustafsson, Tracey-Lea Laba, Arianit Jakupi, Øyvind Melien, Wija Oortwijn, Luka Voncina, Durhane Wong-Rieger, Caridad Pontes, Jf Hans Piepenbrink, Magdalene Wladysiuk, Guenka Petrova, Patricia Vella Bonanno, Corinne Zara, Robert Sauermann, Steven Simoens, Olayinka O Ogunleye, Amanj Kurdi, Wouter Hamelinck, Wania Cristina Silva, Dzintars Gotham, Seung Jin Bae, Johanna C Meyer, Roberta Joppi, Janet Wale, Admir Malaj, John Yfantopoulos, Gisbert Selke, Angela Timoney, Brian Godman, Vincent de Valk, Andrew Hill, Merce Obach Cortadellas, D Tomek, Hye-Young Kwon, Irene Langner, Jurij Fürst, Iva Selke Krulichová, Antony P. Martin, Jolanta Gulbinovič, Iris Hoxha, Eleonora Allocati, Stuart McTaggart, Ieva Greiciute-Kuprijanov, Vanda Marković-Peković, Ileana Mardare

المساهمون: Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Laba, Tracey-Lea, Hill, Ruaraidh

المصدر: Expert review of pharmacoeconomics and outcomes research, Abingdon : Taylor and Francis Ltd., 2021, vol. 21, iss. 4, p. 527-540
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research

مصطلحات موضوعية: Transparency (market), Amortization (business), Medical care -- Cost control, Alternative pricing approaches, cancer medicines, europe, managed entry agreements, minimum effectiveness criteria, multicriteria decision analyses, payers, tiered pricing approaches, transparent pricing approaches, 0302 clinical medicine, Neoplasms, Health care, Pharmacology (medical), Confidentiality, 030212 general & internal medicine, Pharmacology & Pharmacy, Reimbursement, health care economics and organizations, Public economics, 030503 health policy & services, Health Policy, General Medicine, Europe, Models, Economic, Value (economics), Health Policy & Services, Costs and Cost Analysis, 0305 other medical science, Life Sciences & Biomedicine, Scrutiny, Cancer -- Treatment -- Europe, Antineoplastic Agents, Medical care -- Cost control -- Europe, Drug Costs, Patents as Topic, Reimbursement Mechanisms, 03 medical and health sciences, Drug Development, Humans, Drugs -- Law and legislation -- Decision making, 1115 Pharmacology and Pharmaceutical Sciences, 1117 Public Health and Health Services, 1402 Applied Economics, Science & Technology, business.industry, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Health Care Sciences & Services, Sustainability, Business, RA, Delivery of Health Care